Skip to main content
Clinical Trials/CTRI/2014/05/004589
CTRI/2014/05/004589
Completed
Phase 2

A double-blind randomized placebo-controlled feasibility study evaluating individualized homeopathy in managing pain of knee osteoarthritis

Mahesh Bhattacharyya Homoeopathic Medical College Hospital Government of West Bengal0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: M17- Osteoarthritis of knee
Sponsor
Mahesh Bhattacharyya Homoeopathic Medical College Hospital Government of West Bengal
Enrollment
60
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 30, 2014
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Mahesh Bhattacharyya Homoeopathic Medical College Hospital Government of West Bengal

Eligibility Criteria

Inclusion Criteria

  • a)Age between 51\-86 years
  • b)Both sexes
  • c)Clinically diagnosed cases of knee osteoarthritis, as per American
  • College of Rheumatology criteria, suffering from acute painful episodes of the condition; with or without involvement of other joint(s); with or without imaging and/or other investigational
  • d)Patients already undergoing regular oral/topical
  • analgesics/NSAIDs therapy for acute inflammatory episodes of osteoarthritis, provided the medications are stopped completely; patients on life\-saving conventional drug therapies, e.g.
  • anti\-diabetics, anti\-hypertensives, thyroid drugs etc. for co\-morbidities under control, will be continued

Exclusion Criteria

  • a)Severe degeneration of knee joint with marked joint narrowing,varus, or valgus deformity of knee ( \> 12Ã?°); evidenced by imaging or other evidences and requiring surgical intervention
  • b)Non\-ambulant patients
  • c)Self\-reported joint disorders (e.g. inflammatory joint disease,specific arthropathy, severe axis deviations or instabilities, joint or skin infections, joint prostheses of the lower limbs) other than osteoarthritis
  • d)Intra\-articular injections within 2 weeks prior to study entry
  • e)Uncontrolled, unevaluated and/or complicated diabetes mellitus, hypertension, and other co\-morbidities
  • f)Cases with other systemic unevaluated or uncontrolled diseases like cardiovascular, renal, gastro\-intestinal, endocrinal, gynecological
  • diseases etc. or systemic infections affecting quality of life or on other treatment therapies
  • g)Psychiatric illness
  • h)Patients with any vital organ failure
  • i)Recent significant knee surgery within last 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials